close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

JNJ

227.58

+1.12%↑

ABT

93.81

+1.03%↑

MDT

81.87

-1.27%↓

A

114.85

-0.62%↓

VEEV

158.41

-1.09%↓

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

8.5 -0.82

Strong Buy

Price update 28 kwi 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

8.46

Max

8.65

Key metrics

By Trading Economics

Income

-69M

-102M

Sales

-10M

34M

EPS

-5.69

Profit margin

-299.886

Employees

228

EBITDA

4.7M

-18M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+91.69% upside

Market Stats

By TradingEconomics

Market Cap

44M

202M

Previous open

9.32

Previous close

8.5

News Sentiment

By Acuity

6%

94%

4 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 kwi 2026, 23:33 UTC

Hot Stocks

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

DJ

Read

28 kwi 2026, 23:24 UTC

Earnings

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

DJ

Read

28 kwi 2026, 23:15 UTC

Major News Events

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

DJ

Read

28 kwi 2026, 22:46 UTC

Earnings

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

DJ

Read

28 kwi 2026, 22:37 UTC

Earnings

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

DJ

Read

28 kwi 2026, 22:15 UTC

Earnings
Major News Events

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

DJ

Read

28 kwi 2026, 23:33 UTC

Market Talk
Major News Events

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

DJ

Read

28 kwi 2026, 23:31 UTC

Earnings

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

DJ

Read

28 kwi 2026, 23:31 UTC

Earnings

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

DJ

Read

28 kwi 2026, 23:30 UTC

Earnings

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

DJ

Read

28 kwi 2026, 23:30 UTC

Earnings

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

DJ

Read

28 kwi 2026, 23:19 UTC

Market Talk
Earnings

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

DJ

Read

28 kwi 2026, 23:09 UTC

Earnings

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

DJ

Read

28 kwi 2026, 23:03 UTC

Market Talk

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

DJ

Read

28 kwi 2026, 23:01 UTC

Major News Events

NIESR Sees One Rate Rise to 4% in Benign Scenario

DJ

Read

28 kwi 2026, 23:01 UTC

Major News Events

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

DJ

Read

28 kwi 2026, 23:01 UTC

Major News Events

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

DJ

Read

28 kwi 2026, 23:01 UTC

Major News Events

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

DJ

Read

28 kwi 2026, 23:01 UTC

Major News Events

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

DJ

Read

28 kwi 2026, 22:51 UTC

Earnings

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

DJ

Read

28 kwi 2026, 22:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

28 kwi 2026, 22:48 UTC

Market Talk

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

DJ

Read

28 kwi 2026, 22:40 UTC

Market Talk
Major News Events

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

DJ

Read

28 kwi 2026, 22:32 UTC

Earnings

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

DJ

Read

28 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

Pernod Ricard and Brown-Forman End Deal Talks -- Update

DJ

Read

28 kwi 2026, 22:22 UTC

Earnings

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

DJ

Read

28 kwi 2026, 22:17 UTC

Market Talk

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

DJ

Read

28 kwi 2026, 22:14 UTC

Earnings

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

DJ

Read

28 kwi 2026, 22:14 UTC

Earnings

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

DJ

Read

28 kwi 2026, 22:07 UTC

Market Talk
Major News Events

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

91.69% upside

12 Months Forecast

Average 16.6 USD  91.69%

High 28 USD

Low 8 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

4 / 348 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

JNJ

Johnson and Johnson

227.58

↑ +1.12%

ABT

Abbott Laboratories

93.81

↑ +1.03%

MDT

Medtronic PLC

81.87

↓-1.27%

A

Agilent Technologies Inc

114.85

↓-0.62%

VEEV

Veeva Systems Inc

158.41

↓-1.09%
help-icon Live chat